Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

INVESTORS

Annual General Meeting 2026

The Annual General Meeting of BB Biotech AG was held on March 19, 2026 in Schaffhausen.  
 

Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.25 per share

All proposals of BB Biotech AG's Board of Directors were approved by BB Biotech AG's shareholders at its Annual General Meeting.

Shareholders voted in favor of the proposal to pay out a dividend of CHF 2.25 gross per share. Payment will be made on March 25, 2026, the record date is March 24, 2026 and the ex-dividend date is March 23, 2026.

Shareholders re-elected the previous board members Dr. Thomas von Planta (Chairman), Prof. Dr. Mads Krogsgaard Thomsen, Laura Hamill, Dr. Pearl Huang and Camilla Soenderby for another one-year term of office.

Rachael Burri
HEAD OF INVESTOR RELATIONS

Rachael Burri

First point of contact for IR enquiries, financial reports, results calendar, share information, or analyst questions.

Office
Bellevue Asset Management AGTheaterstrasse 128001 Zurich, Switzerland